OS Therapies to report significant survival benefit for OST-HER2 in osteosarcoma

Investing.com Gold reports: OS Therapies to report significant survival benefit for OST-HER2 in osteosarcoma. Full body text was unavailable at ingest time, so this brief is based on headline context.